Expansion of DMF system eyed

The Korea Food and Drug Administration announced on August 12 that it plans to expand the scope of a drug master file system on pharmaceutical bulk materials subject to notification in its bid to ensure better quality and reliance of locally manufactured drugs.

The revised DMF guideline covers 99 pharmaceutical bulk materials including bioequivalence-tested gliclazide from July 1, next year,...